Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.51
Delayed Data
As of Dec 02
 +0.335 / +6.47%
Today’s Change
1.63
Today|||52-Week Range
10.98
-46.61%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$406.4M

Company Description

BioCryst Pharmaceuticals, Inc. is a biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in the pathogenesis of diseases with its focus on therapeutic areas with unmet medical needs. It integrates the disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. The company was founded in 1986 and is headquartered in Birmingham, AL.

Contact Information

BioCryst Pharmaceuticals, Inc.
4505 Emperor Boulevard
Durham North Carolina 27703-8457
P:(919) 859-1302
Investor Relations:
(919) 859-7910

Employees

Shareholders

Other institutional61.76%
Individual stakeholders29.40%
Mutual fund holders16.37%

Top Executives

Jon P. StonehousePresident, Chief Executive Officer & Director
Robert BennettVice President-Investor Relations & Operations
Thomas R. StaabChief Financial Officer, Treasurer, CAO & SVP
William P. SheridanChief Medical Officer & Senior Vice President
Lynne PowellChief Commercial Officer & Senior Vice President